Seattle-based biotech Dendreon is hoping to get U.S. approval for the first cancer drug that would train the body to fight off cancer on its own, with few side effects. But researchers, statisticians and Wall Street analysts are fiercely debating whether there is enough data about this radical new treatment.
Dendreon’s Provenge is a so-called cancer […]
-
Tags
- Cancer News
- Cancer Story
- breast-cancer
- breast_cancer
- american_cancer_society
- cervical_cancer
- cancer_patients
- journal_cancer
- prostate_cancer
- metastatic_breast_cancer
- cancer_treatment
- colorectal_cancer
- john_edwards
- cervical_cancer_vaccine
- cancer_drugs
- breast_cancer_patients
- colon_cancer
- cancer_vaccine
- word_cancer
- cancer_vaccines
- cancer_therapies
- cancer_researchers
- cancer_deaths
- elizabeth_edwards
- cancer
- breast_cancer_cases
- cancer-drug
- breast_cancer_research
- BREAST-CANCER-RISK
- cancer_center
-
Archives
